TVRAX
Price
$18.80
Change
+$0.05 (+0.27%)
Updated
Dec 3 closing price
Net Assets
194.97M
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

TVRAX vs VIGRX

Header iconTVRAX vs VIGRX Comparison
Open Charts TVRAX vs VIGRXBanner chart's image
NAA Allocation A
Price$18.80
Change+$0.05 (+0.27%)
VolumeN/A
Net Assets194.97M
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
TVRAX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
TVRAX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TVRAX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. TVRAX (195M). VIGRX pays higher dividends than TVRAX: VIGRX (0.30) vs TVRAX (0.08). TVRAX was incepted earlier than VIGRX: TVRAX (13 years) vs VIGRX (33 years). TVRAX (1.47) is less costly to investors than VIGRX (0.17). TVRAX is a more actively managed with annual turnover of: 125.00 vs. VIGRX (11.00). TVRAX has a lower initial minimum investment than VIGRX: TVRAX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. TVRAX (-4.58). VIGRX return over 5 years is better than : 99.11 vs. TVRAX (24.17).
TVRAXVIGRXTVRAX / VIGRX
Total Expense Ratio1.450.17853%
Annual Report Gross Expense Ratio1.470.17865%
Fund Existence13 years33 years-
Gain YTD13.45819.76468%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets195M357B0%
Annual Yield % from dividends0.080.3028%
Returns for 1 year-4.5818.49-25%
Returns for 3 years34.63110.8231%
Returns for 5 years24.1799.1124%
Returns for 10 years51.59349.1315%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT